ALL SOURCES

全部资讯 4

把在研试验和前沿论文合在一起看,可以按综合评分或时间排序。本页条数 = 前沿论文 + 临床试验两块之和(导航里的「临床试验」板块只收在招的那部分,不另计入)。

排序:按综合评分按时间

通过脂质辅助聚合物纳米颗粒工程化干扰素-γ增强型嵌合抗原受体巨噬细胞用于癌症免疫治疗

Engineering Interferon-γ-Enhanced Chimeric Antigen Receptor Macrophages via Lipid-Assisted Polymeric Nanoparticles for Cancer Immunotherapy.

PubMed 2026/07/14 发表ACS NanoQ1 · IF 17.3(JCR 2025)

目的 To develop an efficient strategy for in vivo engineering of M1-like CAR-Ms for cancer therapy. 方法 We designed a lentiviral vector encoding a CAR targeting BCMA and a cytokine cassette. Macrophages were transduced and

90.6分
★★★★★

共 4 条